Latest market headlines for LUPIN on Terminal.
22-Oct-2026 22:31:05
Brian Savage, formerly EVP and Interim Global Chief Legal Officer at Teva Pharmaceuticals, appointed as Senior Management Personnel effective October 22, 2026;…
08-Oct-2026 20:59:41
• U.S. FDA approves Lupin's ANDA for Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringe • Approved as bioequivalent to reference l…
01-Oct-2026 10:07:06
• Multicare Pharmaceuticals Philippines, Inc. (MPPI), a step-down subsidiary of Lupin Limited, has completed the buy-back of 30,559 shares. • Consequently, eff…
28-Sept-2026 09:12:08
• Lupin received tentative approval from the U.S. FDA for its New Drug Application for Apixaban Oral Suspension 1.25mg/mL. • The product is an oral liquid form…
04-Sept-2026 17:39:18
• Lupin receives approval from the U.S. FDA for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. • The tablets are bio…
01-Jul-2026 18:20:27
• Nanomi B.V., a wholly owned subsidiary, completed the acquisition of 11,794,497 shares from existing shareholders of Multicare Pharmaceuticals Philippines, I…
01-Jul-2026 16:47:07
• European Medicines Agency (EMA) has approved a change to the terms of marketing authorization for NaMuscla, supported by the Pediatric Investigation Plan (PI…
26-Jun-2026 09:39:49
• Enclosed is a press release titled “Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets". • The U.S. FDA has tentatively approved Lupin'…